Bioclinica, Inc. (BIOC) Tops Q4 EPS by 1c
Tweet Send to a Friend
Bioclinica, Inc. (NASDAQ: BIOC) reported Q4 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $27.61 million versus the consensus estimate of $24.62 million.
For earnings history and earnings-related data on Bioclinica, Inc. (BIOC) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Bioclinica, Inc. (BIOC) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Best Buy (BBY) Posts Q1 adj.-EPS of 32c; Comps Down 1.1%
- Rexnord (RXN) Misses Q4 EPS by 7c; Issues Light Q1 Outlook
- China TechFaith (CNTF) Swings to Q1 Profitl; Guides Q2 Sales
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
